IAEA is sending equipment to detect COVID-19 The International Atomic Energy Agency (IAEA) is dispatching a first batch of equipment to more than 40 countries to enable them to use a nuclear-derived technique to rapidly detect the coronavirus that causes COVID-19. Dozens of laboratories in Africa, Asia, Europe, Latin America and the Caribbean will receive…
Producing LEU-based Mo-99 to reduce the use of HEU Belgium’s Institute for Radioelements (IRE) announced that the company produced its first commercial Molybdenum-99 Low Enriched Uranium (LEU) batch for the US market. This conversion to LEU represents a key milestone for IRE in the global efforts to end the civil use of High Enriched Uranium…
NRG and PALLAS appoint Bertholt Leeftink (CEO) and Gerrit Zalm The NRG Foundation (previously: Foundation ECN) and the Foundation Preparation Pallas-reactor (PALLAS) have made an important step forward. The executive board members and the supervisory board members of both organizations will sit on the boards of both companies, via a so-called “personele unie” (a situation…
Reactor Petten record production of medical isotopes Last month, the reactor in Petten had a record production and was therefore able to continue to provide 30,000 patients daily with medical isotopes. The Corona crisis has caused complications for transport and logistics and due to this the European manufacturers are now turning to NRG. Jojanneke van…
IAEA and Okayama University to Cooperate in Boron Neutron Capture Therapy R&D Boron Neutron Capture Therapy (BNCT) is a non-invasive therapeutic technique for treating invasive malignant tumours. It relies on the use of neutrons for the generation of energetic alpha particles to destroy cells within the tumour, but not in the surrounding tissue. Recent breakthroughs…
Rosatom’s Cyclotron for Development of Nuclear Medicine and Research On July 15-17, 2020 JSC Efremov NIIEFA (Saint-Petersburg), shipped off the equipment, which is part of an isochronous cyclotron СС-30/15. Nine containers of total weight 120 tons were sent to Thailand, where JSC Rusatom Health Care and Kinetics Corporation Ltd. carry out the construction of the…
“Nuclear technologies for a healthier world?” – R&I Days, 23 September 2020 European Research and Innovation Days is the European Commission’s annual flagship Research and Innovation event, bringing together policymakers, researchers, entrepreneurs and the public to debate and shape the future of research and innovation in Europe and beyond. This year, it is a fully virtual…
Lutetium-177, The Increasing Production Of A Promising Radioisotope Lutetium-177 (Lu-177) is considered to be one of the most promising radioisotopes. Radiopharmaceuticals based on Lu-177 have already demonstrated excellent therapeutic performance in several applications, as prostate cancer and gastroenteropancreatic neuroendocrine tumors treatment. Thanks to its efficient performances and results, the demand for Lu-177 is growing. Several…
SCK CEN Radioisotopes Production Marks A Great Record Despite Pandemic In the field of radioisotopes production, SCK CEN efficiently overcame the challenges and limitations obliged by the COVID-19 pandemic. Indeed, SCK CEN’s research reactor BR2 even produced more radioisotopes in 2020 than in 2019. More than 9 million diagnoses and 20,000 treatments have been provided…
NRG And PALLAS Together For A Shared, Innovative Future NRG and PALLAS aim to fuse together as one organisation, as announced by Bertholt Leeftink, CEO NRG/PALLAS. “By combining our forces, we are able to make large steps forward in the development and production of nuclear medicines used for diagnostic purposes and for the treatment of…